Compounds > desogestrel

Page last updated: 2024-08-23

desogestrel and Phlegmasia Alba Dolens

desogestrel has been researched along with Phlegmasia Alba Dolens in 17 studies

Research

Studies (17)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	16 (94.12)	18.2507
2000's	1 (5.88)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bloemenkamp, KW; Büller, HR; Helmerhorst, FM; Rosendaal, FR; Vandenbroucke, JP	1
Henzl, MR	1
Johannisson, E	1
Farmer, R	1
Strobel, E	1
Cramer, DW	1
Westhoff, C	1
Speroff, L	1
Farmer, RD; Hambleton, IR; Kennedy, JG; Lawrenson, RA; Thompson, CR	1
Skjeldestad, FE	1
Schwingl, PJ; Shelton, J	1
Weiss, NS	1
Hamulyak, K; Heijnen, P; Hemker, HC; Nicolaes, GA; Rosing, J; Tans, G; Thomassen, MC; van der Ploeg, PM; van Oerle, R	1
Blais, L; Cusson, J; Heinemann, L; Lewis, M; Spitzer, WO; Suissa, S	1
Jick, H; Jick, SS; Vasilakis, C	1
Helmerhorst, F; Vandenbroucke, JP	1
Girolami, A; Lazzaro, AR; Simioni, P	1

Reviews

1 review(s) available for desogestrel and Phlegmasia Alba Dolens

Article	Year
Oral contraceptives and venous thromboembolism. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1996, Volume: 54, Issue:1 Topics: Clinical Trials as Topic; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Norpregnenes; Risk Factors; Thrombophlebitis; United Kingdom	1996

Other Studies

16 other study(ies) available for desogestrel and Phlegmasia Alba Dolens

Article	Year
Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet (London, England), 1995, Dec-16, Volume: 346, Issue:8990 Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Factor V; Female; Humans; Middle Aged; Mutation; Progestins; Risk Factors; Thrombophlebitis	1995
Safety of modern oral contraceptives. Lancet (London, England), 1996, Jan-27, Volume: 347, Issue:8996 Topics: Contraceptives, Oral; Desogestrel; Female; Humans; Norpregnenes; Progesterone Congeners; Thrombophlebitis	1996
Safety of modern oral contraceptives. The International Committee for Research in Reproduction. Lancet (London, England), 1996, Jan-27, Volume: 347, Issue:8996 Topics: Contraceptives, Oral; Desogestrel; Drug and Narcotic Control; Female; Humans; Norpregnenes; Progesterone Congeners; Thrombophlebitis	1996
Safety of modern oral contraceptives. Lancet (London, England), 1996, Jan-27, Volume: 347, Issue:8996 Topics: Adolescent; Adult; Contraceptives, Oral; Desogestrel; Female; Humans; Middle Aged; Norpregnenes; Thrombophlebitis; Thrombosis	1996
[Sexual abstinence of thrombosis? Comment on the controversy regarding the "pill of the 3rd generation"]. Fortschritte der Medizin, 1995, Nov-30, Volume: 113, Issue:33 Topics: Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Product Surveillance, Postmarketing; Progesterone Congeners; Risk Factors; Sexual Abstinence; Thrombophlebitis; World Health Organization	1995
Safety of combined oral contraceptive pills. Lancet (London, England), 1996, Feb-24, Volume: 347, Issue:9000 Topics: Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Norpregnenes; Progesterone Congeners; Thromboembolism; Thrombophlebitis	1996
Factor V Leiden and third-generation oral contraceptives. Lancet (London, England), 1996, Feb-10, Volume: 347, Issue:8998 Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Factor V; Female; Humans; Mutation; Risk Factors; Thrombophlebitis	1996
Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet (London, England), 1997, Jan-11, Volume: 349, Issue:9045 Topics: Adolescent; Adult; Case-Control Studies; Confounding Factors, Epidemiologic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Logistic Models; Middle Aged; Odds Ratio; Population Surveillance; Progesterone Congeners; Risk Factors; Thromboembolism; Thrombophlebitis; United Kingdom	1997
Increased number of induced abortions in Norway after media coverage of adverse vascular events from the use of third-generation oral contraceptives. Contraception, 1997, Volume: 55, Issue:1 Topics: Abortion, Induced; Adolescent; Adult; Contraception; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Incidence; Norway; Pregnancy; Risk Factors; Single Person; Students; Thrombophlebitis	1997
Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives. Contraception, 1997, Volume: 55, Issue:3 Topics: Adolescent; Adult; Age Factors; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Incidence; Levonorgestrel; Myocardial Infarction; Norethindrone; Norgestrel; Risk Factors; Thrombophlebitis; United States	1997
Bias in studies of venous thromboembolism in relation to the use of new formulations of oral contraceptives. Contraception, 1997, Volume: 55, Issue:3 Topics: Adolescent; Adult; Age Factors; Bias; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Research Design; Thrombophlebitis	1997
Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives. British journal of haematology, 1997, Volume: 97, Issue:1 Topics: Adolescent; Adult; Aged; Contraceptives, Oral, Combined; Desogestrel; Factor V; Female; Hemostasis; Heterozygote; Humans; Levonorgestrel; Male; Middle Aged; Norgestrel; Norpregnenes; Protein C; Thrombin; Thrombophlebitis	1997
First-time use of newer oral contraceptives and the risk of venous thromboembolism. Contraception, 1997, Volume: 56, Issue:3 Topics: Adult; Austria; Case-Control Studies; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; France; Germany; Humans; Logistic Models; Norpregnenes; Progesterone Congeners; Pulmonary Embolism; Risk Factors; Switzerland; Thrombophlebitis; United Kingdom; Veins	1997
Pregnancies and terminations after 1995 warning about third-generation oral contraceptives. Lancet (London, England), 1998, May-09, Volume: 351, Issue:9113 Topics: Abortion, Legal; Adult; Cohort Studies; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Norpregnenes; Pregnancy; Pregnancy Rate; Risk Factors; Thrombophlebitis	1998
[Third-generation pill]. Nederlands tijdschrift voor geneeskunde, 2000, Apr-22, Volume: 144, Issue:17 Topics: Adult; Contraception; Contraceptives, Oral, Synthetic; Contraindications; Counseling; Desogestrel; Female; Humans; Levonorgestrel; Netherlands; Risk Assessment; Secondary Prevention; Thrombophlebitis	2000
Deep vein thrombophlebitis of a leg in a young female with heterozygous protein C deficiency taking oral contraceptives. Folia haematologica (Leipzig, Germany : 1928), 1990, Volume: 117, Issue:3 Topics: Adult; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Heterozygote; Humans; Male; Norpregnenes; Progesterone Congeners; Protein C Deficiency; Thrombophlebitis	1990